GHK-Cu + Matrixyl 3000 Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: topical copper and matrikine blend

Cosmetic Blend blend Blend verified

Also known as: Copper Matrixyl blend

Quick Facts

Reference Sizes
100 mg total (component ratio supplier-defined)
Components
GHK-Cu + Matrixyl 3000
Storage
Protect from heat light and incompatible formulation ingredients; follow the batch certificate
Solubility
Matrixyl 3000 is itself a formulated mixture of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7; compatibility depends on vehicle pH and ratio

Blend Components

This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.

Component
GHK-Cu
Calculator Profile
Component
Matrixyl 3000
Calculator Profile
Open All in Blend Calculator

Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.

Catalog Description

GHK-Cu + Matrixyl 3000 combines GHK-Cu + Matrixyl 3000 into a single research protocol. Each component is independently studied; this entry summarizes the individual evidence base for the combination, since no unified safety/efficacy dataset covers the mixed formulation unless noted below. GHK-Cu: Copper tripeptide (Gly-His-Lys) first isolated from human plasma by Loren Pickart (1973); stimulates collagen/elastin/GAG synthesis and modulates ~4,000 human genes toward a younger expression profile - among the best-evidenced cosmetic/regenerative peptides. Matrixyl 3000: Research combination pairing Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7. Palmitoylated form of Tripeptide-1 (GHK); still shows biological activity as a matrikine signaling molecule but functions primarily as a delivery-enhancing vehicle when formulated alongside mineral salts (e. Palmitoylated tetrapeptide, often combined with Matrixyl (Palmitoyl Pentapeptide-4) in commercial formulations (e. This is a community-stacking combination assembled from two independently studied compounds rather than a pharmaceutical sponsor's dedicated fixed-dose combination program - no dedicated human combination trial exists for this exact pairing as of this writing.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
Not established for the blend
Onset
Finished topical peptide studies generally assess outcomes after 4-12 weeks; this does not validate the raw blend
Administration Routes (Research)
Topical formulationLaboratory use

Reported Research Effects

Reported Research Side Effects

Data source: Cosmetic-peptide reviews, a human finished-product study, and formulation identity sources

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Interactions

Flagged Avoid / Caution Combinations (Research)

Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.

Research Notes

Matrixyl 3000 is not a single peptide and is distinct from palmitoyl pentapeptide-4 sold as Matrixyl. The catalog size does not specify component ratios, so it cannot support concentration calculations.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

Current cosmeceutical peptide review — PubMed Central (NIH)
https://pmc.ncbi.nlm.nih.gov/articles/PMC11946782/
Palmitoyl tripeptide-1 and tetrapeptide-7 eye-cream study — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/38932444/
GHK-Cu skin-permeation review — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/39795193/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top